Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NagaseFRA:P22 +1.67%60 EBIT per Share is €0.66 as of Mar. 2026. GuruFocus rates FRA:P22 with a GF Score™ of 60/100 and a GF Value™ of €4.44 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,338 Chemicals companies, Nagase ranks better than 73.24% on this metric.
Nagase's EBIT per Share for the
three
months ended in Mar. 2026 was €0.15.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.66.
During the past 12 months, the average EBIT per Share Growth Rate of Nagase was 20.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 14.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 15.10% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 11.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Nagase's EBIT per Share or its related term are showing as below:
FRA:P22'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -28.1 Med: 5.1 Max: 22.2
Current: 14.8
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Nagase was 22.20% per year. The lowest was -28.10% per year. And the median was 5.10% per year.
FRA:P22's 3-Year EBIT Growth Rate is ranked better than 73.24% of 1338
companies
in the Chemicals industry
Industry Median: -1.2
vs FRA:P22: 14.80
Nagase's EBIT for the
three
months ended in Mar. 2026 was €63 Mil.
Nagase (FRA:P22) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Nagase EBIT per Share Related Terms
Nagase EBIT per Share Historical Data
* Premium members only.
The historical data trend for Nagase's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.66
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nagase (FRA:P22) has a EBIT per Share of €0.66 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Nagase and its competitors. According to the industry distribution chart, Nagase ranks #358 out of 1338 companies in the Chemicals industry, placing it in the top 26.8%.
Is Nagase's EBIT per Share too high?
Nagase's current EBIT per Share is €0.66. Based on the distribution chart, Nagase ranks #358 out of 1338 companies in the Chemicals industry, which is above the industry midpoint. Overall, Nagase has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nagase's EBIT per Share compare to LIN and SHW?
According to the Chemicals industry distribution chart, Nagase ranks #358 out of 1338 companies for EBIT per Share. This puts Nagase in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Nagase and its competitors. Nagase's current EBIT per Share is €0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nagase stock overvalued right now?
Based on GuruFocus' analysis, Nagase (FRA:P22) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.44, compared to a current price of €6.10 — trading 37.4% above its estimated fair value. The current EBIT per Share is €0.66. Nagase's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Nagase (FRA:P22), the current EBIT per Share is €0.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nagase (FRA:P22) Overvalued in 2026?
Based on GuruFocus' analysis, Nagase stock appears to be overvalued.
The current stock price of €6.10 is trading 37.4% above its estimated GF Value™ of €4.44.
GuruFocus considers Nagase to be Significantly Overvalued.
Key valuation signals for FRA:P22:
EBIT per Share: €0.66
GF Value™: €4.44 vs. price of €6.10 (37.4% above fair value)
No single metric tells the full story. See the FRA:P22 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nagase & Co Ltd is a Japan-based trading company focused on chemicals and related products. The company operates through five segments. The Electronics and Energy segment covers semiconductors, components, AR/VR, renewable energy, and displays. The Functional Material segment handles paints, inks, resins, chemicals, films, and sanitary materials. The Life Related segment offers pharmaceuticals, agrochemicals, food ingredients, cosmetics, reagents, and medical devices. The Mobility segment provides materials and products for batteries, electrification, in-vehicle electronics, and autonomous driving. The Processing Material segment deals with plastics, resins, molding machines, and molds, while Others includes information processing and functional services.
60GF Score
Get the complete analysis for FRA:P22
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:P22 has been successfully added to your 
